Roivant Sciences Ltd. (ROIV)

Healthcare · Biotechnology · NASDAQ

Roivant Sciences Ltd. (ROIV) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $26.25B and a free-cash-flow yield of -3.0%. Over the most recent reported fiscal year, revenue declined 71.6%.

Market cap	$26.25B
Trailing P/E	—
FCF yield	-3.0%
Revenue growth (YoY)	-71.6%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live ROIV data on Nama Insights →

Recent Congressional trades

Roivant Sciences Ltd. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Lisa McClain	House	Sell	$1,001 - $15,000	Nov 1, 2025
Lisa McClain	House	Sell	$1,001 - $15,000	Nov 1, 2025